Global Meningococcal Group B Vaccine Market Research Report 2024(Status and Outlook)
Report Overview:
Meningococcal B vaccinecan help protect againstmeningococcaldisease caused byserogroup B.
The Global Meningococcal Group B Vaccine Market Size was estimated at USD 1242.58 million in 2023 and is projected to reach USD 2038.47 million by 2029, exhibiting a CAGR of 8.60% during the forecast period.
This report provides a deep insight into the global Meningococcal Group B Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Meningococcal Group B Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Meningococcal Group B Vaccine market in any manner.
Global Meningococcal Group B Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Pfizer
Market Segmentation (by Type)
Bexsero
Trumenba
Other
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Group B Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Meningococcal B vaccinecan help protect againstmeningococcaldisease caused byserogroup B.
The Global Meningococcal Group B Vaccine Market Size was estimated at USD 1242.58 million in 2023 and is projected to reach USD 2038.47 million by 2029, exhibiting a CAGR of 8.60% during the forecast period.
This report provides a deep insight into the global Meningococcal Group B Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Meningococcal Group B Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Meningococcal Group B Vaccine market in any manner.
Global Meningococcal Group B Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Pfizer
Market Segmentation (by Type)
Bexsero
Trumenba
Other
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Meningococcal Group B Vaccine Market
- Overview of the regional outlook of the Meningococcal Group B Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Group B Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Meningococcal Group B Vaccine
1.2 Key Market Segments
1.2.1 Meningococcal Group B Vaccine Segment by Type
1.2.2 Meningococcal Group B Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MENINGOCOCCAL GROUP B VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Meningococcal Group B Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Meningococcal Group B Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MENINGOCOCCAL GROUP B VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Meningococcal Group B Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Meningococcal Group B Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Meningococcal Group B Vaccine Sales Sites, Area Served, Product Type
3.6 Meningococcal Group B Vaccine Market Competitive Situation and Trends
3.6.1 Meningococcal Group B Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Meningococcal Group B Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MENINGOCOCCAL GROUP B VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Meningococcal Group B Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MENINGOCOCCAL GROUP B VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MENINGOCOCCAL GROUP B VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Group B Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Meningococcal Group B Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Meningococcal Group B Vaccine Price by Type (2019-2024)
7 MENINGOCOCCAL GROUP B VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Group B Vaccine Market Sales by Application (2019-2024)
7.3 Global Meningococcal Group B Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Meningococcal Group B Vaccine Sales Growth Rate by Application (2019-2024)
8 MENINGOCOCCAL GROUP B VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Meningococcal Group B Vaccine Sales by Region
8.1.1 Global Meningococcal Group B Vaccine Sales by Region
8.1.2 Global Meningococcal Group B Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Meningococcal Group B Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Meningococcal Group B Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Meningococcal Group B Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Meningococcal Group B Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GSK
9.1.1 GSK Meningococcal Group B Vaccine Basic Information
9.1.2 GSK Meningococcal Group B Vaccine Product Overview
9.1.3 GSK Meningococcal Group B Vaccine Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Meningococcal Group B Vaccine SWOT Analysis
9.1.6 GSK Recent Developments
9.2 Pfizer
9.2.1 Pfizer Meningococcal Group B Vaccine Basic Information
9.2.2 Pfizer Meningococcal Group B Vaccine Product Overview
9.2.3 Pfizer Meningococcal Group B Vaccine Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Meningococcal Group B Vaccine SWOT Analysis
9.2.6 Pfizer Recent Developments
10 MENINGOCOCCAL GROUP B VACCINE MARKET FORECAST BY REGION
10.1 Global Meningococcal Group B Vaccine Market Size Forecast
10.2 Global Meningococcal Group B Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Meningococcal Group B Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Meningococcal Group B Vaccine Market Size Forecast by Region
10.2.4 South America Meningococcal Group B Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Meningococcal Group B Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Meningococcal Group B Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Type (2025-2030)
11.1.2 Global Meningococcal Group B Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Meningococcal Group B Vaccine by Type (2025-2030)
11.2 Global Meningococcal Group B Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Meningococcal Group B Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Meningococcal Group B Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Meningococcal Group B Vaccine
1.2 Key Market Segments
1.2.1 Meningococcal Group B Vaccine Segment by Type
1.2.2 Meningococcal Group B Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MENINGOCOCCAL GROUP B VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Meningococcal Group B Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Meningococcal Group B Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MENINGOCOCCAL GROUP B VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Meningococcal Group B Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Meningococcal Group B Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Meningococcal Group B Vaccine Sales Sites, Area Served, Product Type
3.6 Meningococcal Group B Vaccine Market Competitive Situation and Trends
3.6.1 Meningococcal Group B Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Meningococcal Group B Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MENINGOCOCCAL GROUP B VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Meningococcal Group B Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MENINGOCOCCAL GROUP B VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MENINGOCOCCAL GROUP B VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Group B Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Meningococcal Group B Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Meningococcal Group B Vaccine Price by Type (2019-2024)
7 MENINGOCOCCAL GROUP B VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Group B Vaccine Market Sales by Application (2019-2024)
7.3 Global Meningococcal Group B Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Meningococcal Group B Vaccine Sales Growth Rate by Application (2019-2024)
8 MENINGOCOCCAL GROUP B VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Meningococcal Group B Vaccine Sales by Region
8.1.1 Global Meningococcal Group B Vaccine Sales by Region
8.1.2 Global Meningococcal Group B Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Meningococcal Group B Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Meningococcal Group B Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Meningococcal Group B Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Meningococcal Group B Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GSK
9.1.1 GSK Meningococcal Group B Vaccine Basic Information
9.1.2 GSK Meningococcal Group B Vaccine Product Overview
9.1.3 GSK Meningococcal Group B Vaccine Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Meningococcal Group B Vaccine SWOT Analysis
9.1.6 GSK Recent Developments
9.2 Pfizer
9.2.1 Pfizer Meningococcal Group B Vaccine Basic Information
9.2.2 Pfizer Meningococcal Group B Vaccine Product Overview
9.2.3 Pfizer Meningococcal Group B Vaccine Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Meningococcal Group B Vaccine SWOT Analysis
9.2.6 Pfizer Recent Developments
10 MENINGOCOCCAL GROUP B VACCINE MARKET FORECAST BY REGION
10.1 Global Meningococcal Group B Vaccine Market Size Forecast
10.2 Global Meningococcal Group B Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Meningococcal Group B Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Meningococcal Group B Vaccine Market Size Forecast by Region
10.2.4 South America Meningococcal Group B Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Meningococcal Group B Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Meningococcal Group B Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Type (2025-2030)
11.1.2 Global Meningococcal Group B Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Meningococcal Group B Vaccine by Type (2025-2030)
11.2 Global Meningococcal Group B Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Meningococcal Group B Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Meningococcal Group B Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Meningococcal Group B Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Meningococcal Group B Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Meningococcal Group B Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Group B Vaccine as of 2022)
Table 10. Global Market Meningococcal Group B Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Meningococcal Group B Vaccine Sales Sites and Area Served
Table 12. Manufacturers Meningococcal Group B Vaccine Product Type
Table 13. Global Meningococcal Group B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Meningococcal Group B Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningococcal Group B Vaccine Market Challenges
Table 22. Global Meningococcal Group B Vaccine Sales by Type (Kilotons)
Table 23. Global Meningococcal Group B Vaccine Market Size by Type (M USD)
Table 24. Global Meningococcal Group B Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Meningococcal Group B Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Meningococcal Group B Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Meningococcal Group B Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Meningococcal Group B Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Meningococcal Group B Vaccine Sales (Kilotons) by Application
Table 30. Global Meningococcal Group B Vaccine Market Size by Application
Table 31. Global Meningococcal Group B Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Meningococcal Group B Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Meningococcal Group B Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Meningococcal Group B Vaccine Market Share by Application (2019-2024)
Table 35. Global Meningococcal Group B Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Meningococcal Group B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Meningococcal Group B Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Meningococcal Group B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Meningococcal Group B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Meningococcal Group B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Meningococcal Group B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Meningococcal Group B Vaccine Basic Information
Table 44. GSK Meningococcal Group B Vaccine Product Overview
Table 45. GSK Meningococcal Group B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Meningococcal Group B Vaccine SWOT Analysis
Table 48. GSK Recent Developments
Table 49. Pfizer Meningococcal Group B Vaccine Basic Information
Table 50. Pfizer Meningococcal Group B Vaccine Product Overview
Table 51. Pfizer Meningococcal Group B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Pfizer Business Overview
Table 53. Pfizer Meningococcal Group B Vaccine SWOT Analysis
Table 54. Pfizer Recent Developments
Table 55. Global Meningococcal Group B Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Meningococcal Group B Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Meningococcal Group B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Meningococcal Group B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Meningococcal Group B Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Meningococcal Group B Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Meningococcal Group B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Meningococcal Group B Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Meningococcal Group B Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Meningococcal Group B Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Meningococcal Group B Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Meningococcal Group B Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Meningococcal Group B Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Meningococcal Group B Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Meningococcal Group B Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Meningococcal Group B Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Group B Vaccine as of 2022)
Table 10. Global Market Meningococcal Group B Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Meningococcal Group B Vaccine Sales Sites and Area Served
Table 12. Manufacturers Meningococcal Group B Vaccine Product Type
Table 13. Global Meningococcal Group B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Meningococcal Group B Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningococcal Group B Vaccine Market Challenges
Table 22. Global Meningococcal Group B Vaccine Sales by Type (Kilotons)
Table 23. Global Meningococcal Group B Vaccine Market Size by Type (M USD)
Table 24. Global Meningococcal Group B Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Meningococcal Group B Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Meningococcal Group B Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Meningococcal Group B Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Meningococcal Group B Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Meningococcal Group B Vaccine Sales (Kilotons) by Application
Table 30. Global Meningococcal Group B Vaccine Market Size by Application
Table 31. Global Meningococcal Group B Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Meningococcal Group B Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Meningococcal Group B Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Meningococcal Group B Vaccine Market Share by Application (2019-2024)
Table 35. Global Meningococcal Group B Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Meningococcal Group B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Meningococcal Group B Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Meningococcal Group B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Meningococcal Group B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Meningococcal Group B Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Meningococcal Group B Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Meningococcal Group B Vaccine Basic Information
Table 44. GSK Meningococcal Group B Vaccine Product Overview
Table 45. GSK Meningococcal Group B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Meningococcal Group B Vaccine SWOT Analysis
Table 48. GSK Recent Developments
Table 49. Pfizer Meningococcal Group B Vaccine Basic Information
Table 50. Pfizer Meningococcal Group B Vaccine Product Overview
Table 51. Pfizer Meningococcal Group B Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Pfizer Business Overview
Table 53. Pfizer Meningococcal Group B Vaccine SWOT Analysis
Table 54. Pfizer Recent Developments
Table 55. Global Meningococcal Group B Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Meningococcal Group B Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Meningococcal Group B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Meningococcal Group B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Meningococcal Group B Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Meningococcal Group B Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Meningococcal Group B Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Meningococcal Group B Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Meningococcal Group B Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Meningococcal Group B Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Meningococcal Group B Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Meningococcal Group B Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Meningococcal Group B Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Meningococcal Group B Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Meningococcal Group B Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Group B Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Meningococcal Group B Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Meningococcal Group B Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Group B Vaccine Market Size by Country (M USD)
Figure 11. Meningococcal Group B Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Meningococcal Group B Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Meningococcal Group B Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Meningococcal Group B Vaccine Market Share by Type
Figure 18. Sales Market Share of Meningococcal Group B Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Meningococcal Group B Vaccine by Type in 2023
Figure 20. Market Size Share of Meningococcal Group B Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Meningococcal Group B Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Meningococcal Group B Vaccine Market Share by Application
Figure 24. Global Meningococcal Group B Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Meningococcal Group B Vaccine Sales Market Share by Application in 2023
Figure 26. Global Meningococcal Group B Vaccine Market Share by Application (2019-2024)
Figure 27. Global Meningococcal Group B Vaccine Market Share by Application in 2023
Figure 28. Global Meningococcal Group B Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Meningococcal Group B Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Meningococcal Group B Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Meningococcal Group B Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Meningococcal Group B Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Meningococcal Group B Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Meningococcal Group B Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region in 2023
Figure 44. China Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Meningococcal Group B Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Meningococcal Group B Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Meningococcal Group B Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Meningococcal Group B Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Meningococcal Group B Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Meningococcal Group B Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Meningococcal Group B Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Meningococcal Group B Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Meningococcal Group B Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Group B Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Meningococcal Group B Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Meningococcal Group B Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Group B Vaccine Market Size by Country (M USD)
Figure 11. Meningococcal Group B Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Meningococcal Group B Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Meningococcal Group B Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Meningococcal Group B Vaccine Market Share by Type
Figure 18. Sales Market Share of Meningococcal Group B Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Meningococcal Group B Vaccine by Type in 2023
Figure 20. Market Size Share of Meningococcal Group B Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Meningococcal Group B Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Meningococcal Group B Vaccine Market Share by Application
Figure 24. Global Meningococcal Group B Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Meningococcal Group B Vaccine Sales Market Share by Application in 2023
Figure 26. Global Meningococcal Group B Vaccine Market Share by Application (2019-2024)
Figure 27. Global Meningococcal Group B Vaccine Market Share by Application in 2023
Figure 28. Global Meningococcal Group B Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Meningococcal Group B Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Meningococcal Group B Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Meningococcal Group B Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Meningococcal Group B Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Meningococcal Group B Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Meningococcal Group B Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region in 2023
Figure 44. China Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Meningococcal Group B Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Meningococcal Group B Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Meningococcal Group B Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Meningococcal Group B Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Meningococcal Group B Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Meningococcal Group B Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Meningococcal Group B Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Meningococcal Group B Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Meningococcal Group B Vaccine Market Share Forecast by Application (2025-2030)
